Ovid Therapeutics Inc. (OVID)
Largest Insider Buys in Sector
OVID Stock Price History Chart
OVID Stock Performance
About Ovid Therapeutics Inc.
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment of seizures associated with tuberous sclerosis complex and infantile spasms; and OV350, a small molecule for treating epilepsies. It also develops OV882, a short hairpin RNA gene therapy for the treatment of angelman syndrome; and OV815 for the treatment of kinesin-family of proteins associated neurological disorder. The company has license and collaboration agreements with Healx, AstraZeneca AB, H. Lundbeck A/S, and Northwestern University, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York.
Insider Activity of Ovid Therapeutics Inc.
Over the last 12 months, insiders at Ovid Therapeutics Inc. have bought $50,364 and sold $0 worth of Ovid Therapeutics Inc. stock.
On average, over the past 5 years, insiders at Ovid Therapeutics Inc. have bought $1.75M and sold $126,203 worth of stock each year.
Highest buying activity among insiders over the last 12 months: LEVIN JEREMY M (CEO) — $50,364.
The last purchase of 18,248 shares for transaction amount of $50,364 was made by LEVIN JEREMY M (CEO) on 2024‑03‑18.
List of Insider Buy and Sell Transactions, Ovid Therapeutics Inc.
| 2024-03-18 | LEVIN JEREMY M | CEO | 18,248 0.0261% | $2.76 | $50,364 | +12.82% | ||
| 2021-07-14 | Sale | Rakhit Amit | President and CMO | 34,017 0.0508% | $3.71 | $126,203 | -10.93% | |
| 2020-08-28 | LEVIN JEREMY M | CEO | 8,488 0.0143% | $5.84 | $49,570 | -33.90% | ||
| 2019-10-08 | TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 2M 4.1699% | $2.50 | $5M | +65.16% | ||
| 2019-10-08 | LEVIN JEREMY M | CEO | 60,000 0.1251% | $2.50 | $150,000 | +65.16% | ||
| 2019-02-26 | Bernstein Karen | director | 10,000 0.0325% | $2.02 | $20,210 | +7.32% | ||
| 2019-02-22 | LEVIN JEREMY M | CEO | 75,000 0.2617% | $2.00 | $150,000 | +15.34% | ||
| 2018-08-14 | Bernstein Karen | director | 20,000 0.0386% | $3.12 | $62,300 | -60.76% | ||
| 2018-08-14 | WILLIAMS DOUGLAS E | director | 10,000 0.0201% | $3.24 | $32,442 | -60.76% | ||
| 2017-08-25 | LEVIN JEREMY M | CEO | 30,668 0.062% | $3.58 | $109,638 | +20.31% |
Insider Historical Profitability
| LEVIN JEREMY M | CEO | 3616715 8.1954% | $0.71 | 5 | 0 | +33.6% |
| TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 5750000 8.1352% | $0.71 | 1 | 0 | +65.16% |
| Rakhit Amit | President and CMO | 726823 1.0283% | $0.71 | 0 | 1 | |
| Bernstein Karen | director | 20000 0.0283% | $0.71 | 2 | 0 | <0.0001% |
| WILLIAMS DOUGLAS E | director | 5000 0.0071% | $0.71 | 1 | 0 | <0.0001% |
Institutional Investor Ownership
| Ecor1 Capital Llc | $18.66M | 8.62 | 6.12M | 0% | +$0 | 0.47 | |
| Helm Capital Management LLC | $16.21M | 7.49 | 5.32M | 0% | +$0 | 0.48 | |
| BlackRock | $12.8M | 5.91 | 4.2M | -2.88% | -$380,118.44 | <0.0001 | |
| Bvf Inc Il | $11.75M | 5.43 | 3.85M | -43.75% | -$9.14M | 0.09 | |
| Madison Avenue Partners, LP | $11.13M | 5.14 | 3.65M | 0% | +$0 | 1.82 | |
| The Vanguard Group | $9.08M | 4.2 | 2.98M | -0.45% | -$41,080.45 | <0.0001 | |
| Artal Group S A | $7.63M | 3.52 | 2.5M | 0% | +$0 | 0.04 | |
| Acadian Asset Management | $5.05M | 2.33 | 1.66M | 0% | +$0 | 0.02 | |
| JPMorgan Chase | $4.81M | 2.22 | 1.58M | -3.29% | -$163,727.05 | <0.0001 | |
| TLS Advisors LLC | $4.03M | 1.86 | 1.32M | 0% | +$0 | 9.37 | |
| Geode Capital Management | $3.84M | 1.78 | 1.26M | +2.2% | +$82,835.24 | <0.0001 | |
| State Street | $3.52M | 1.63 | 1.16M | +3.15% | +$107,664.99 | <0.0001 | |
| Prosight Management Lp | $3M | 1.39 | 983,200 | New | +$3M | 0.83 | |
| Blue Owl Capital Holdings Lp | $2.64M | 1.22 | 864,822 | 0% | +$0 | 0.5 | |
| Northern Trust | $1.47M | 0.68 | 480,867 | -2% | -$29,905.26 | <0.0001 | |
| Wells Fargo | $1.32M | 0.61 | 433,872 | -3.28% | -$44,892.93 | <0.0001 | |
| Fft Wealth Management Llc | $1.26M | 0.58 | 414,022 | +4.61% | +$55,656.40 | 0.11 | |
| Bridgeway Capital Management | $1.09M | 0.5 | 357,870 | -18.55% | -$248,498.86 | 0.02 | |
| Dimensional Fund Advisors | $1.04M | 0.48 | 342,169 | +40.64% | +$301,565.86 | <0.0001 | |
| Ubs Oconnor Llc | $791,475.00 | 0.37 | 259,500 | +79.58% | +$350,750.00 | 0.07 | |
| BNY Mellon | $700,136.00 | 0.32 | 229,553 | -7.74% | -$58,730.75 | <0.0001 | |
| Wellington Management Company | $679,824.00 | 0.31 | 222,893 | New | +$679,824.00 | <0.0001 | |
| Charles Schwab | $493,514.00 | 0.23 | 161,808 | 0% | +$0 | <0.0001 | |
| Renaissance Technologies | $478,000.00 | 0.22 | 156,800 | +206.25% | +$321,918.37 | <0.01 | |
| Citadel Advisors LLC | $449,384.00 | 0.21 | 147,339 | +1,215.29% | +$415,217.90 | <0.0001 | |
| Millennium Management LLC | $445,193.00 | 0.21 | 145,965 | New | +$445,193.00 | <0.0001 | |
| Empowered Funds Llc | $390,614.00 | 0.18 | 128,070 | +8.13% | +$29,356.29 | 0.01 | |
| Nuveen | $363,295.00 | 0.17 | 119,113 | +4.41% | +$15,335.42 | <0.0001 | |
| Assenagon Asset Management S.A. | $348,508.00 | 0.16 | 114,265 | +45.6% | +$109,147.22 | <0.01 | |
| Morgan Stanley | $304,856.00 | 0.14 | 99,953 | -25.38% | -$103,660.13 | <0.0001 | |
| Fidelity Investments | $262,931.00 | 0.12 | 86,207 | +1.15% | +$2,995.10 | <0.0001 | |
| Connor Clark & Lunn Investment Management Ltd | $256,911.00 | 0.12 | 84,233 | +3.77% | +$9,326.91 | <0.01 | |
| RhumbLine Advisers | $251,875.00 | 0.12 | 82,584 | +3.66% | +$8,899.68 | <0.0001 | |
| Tejara Capital Ltd | $223,117.00 | 0.1 | 73,153 | 0% | +$0 | 0.08 | |
| UBS | $223,937.00 | 0.1 | 73,422 | +2.07% | +$4,541.45 | <0.0001 | |
| D. E. Shaw & Co. | $217,355.00 | 0.1 | 71,264 | -8.95% | -$21,359.13 | <0.0001 | |
| Squarepoint Ops LLC | $208,446.00 | 0.1 | 68,343 | +500.5% | +$173,733.98 | <0.01 | |
| Jacobs Levy Equity Management | $190,140.00 | 0.09 | 62,341 | 0% | +$0 | <0.01 | |
| Goldman Sachs | $179,901.00 | 0.08 | 58,984 | -4.55% | -$8,573.54 | <0.0001 | |
| Jane Street Capital | $163,419.00 | 0.08 | 53,580 | +5.26% | +$8,170.95 | <0.0001 | |
| Scotiabank | $134,664.00 | 0.06 | 44,152 | 0% | +$0 | <0.0001 | |
| Barclays | $128,000.00 | 0.06 | 42,136 | -48.65% | -$121,280.43 | <0.0001 | |
| Two Sigma | $124,040.00 | 0.06 | 40,669 | New | +$124,040.00 | <0.0001 | |
| SG Americas Securities, LLC | $110,000.00 | 0.05 | 35,938 | -9.69% | -$11,796.43 | <0.01 | |
| Invesco | $90,140.00 | 0.04 | 29,554 | -1.11% | -$1,009.55 | <0.0001 | |
| American International Group | $89,627.00 | 0.04 | 29,386 | -0.85% | -$771.65 | <0.0001 | |
| First Manhattan Co. | $79,300.00 | 0.04 | 26,000 | 0% | +$0 | <0.0001 | |
| The Manufacturers Life Insurance Company | $79,239.00 | 0.04 | 25,980 | +4.55% | +$3,446.50 | <0.0001 | |
| Prelude Capital | $77,943.00 | 0.04 | 25,555 | New | +$77,943.00 | 0.01 | |
| Tower Research Capital | $73,612.00 | 0.03 | 24,135 | +450.65% | +$60,243.81 | <0.01 |